Location History:
- Lille, FR (2015)
- La Madeleine, FR (2015 - 2022)
Company Filing History:
3 out of 61 
3 out of 1,744 
4 out of 832,880 Years Active: 2015-2025
Title: Innovator Spotlight: Anne-Sophie Debrie of La Madeleine, France
Introduction
Anne-Sophie Debrie is a distinguished inventor based in La Madeleine, France, known for her significant contributions to the field of biomedical research. With a portfolio of 8 patents, her innovative work primarily focuses on developing effective solutions against various bacterial strains.
Latest Patents
One of her latest innovations involves the development of strains expressing serotype 3 fimbriae. Specifically, she has created a Fim3-producing BPZE1 derivative that boasts stable fim3 expression, which offers enhanced protection in mice against clinical isolates that only produce Fim3. Importantly, the fim3 expression in BPZE1f3 has been shown not to compromise protective efficacy against Fim2+ strains or strains that do not produce either Fim2 or Fim3. This advancement highlights her dedication to improving protective measures against bacterial infections.
Career Highlights
Throughout her career, Anne-Sophie Debrie has worked with reputable organizations, including the Institut Pasteur de Lille. Her research and inventions have played a critical role in advancing medical science, particularly in understanding and targeting bacterial pathogens.
Collaborations
Anne-Sophie has collaborated with prominent figures in her field, including Camille Locht and Dominique Raze. These partnerships have facilitated groundbreaking research and innovations, contributing to her impressive body of work.
Conclusion
With her expertise and innovative spirit, Anne-Sophie Debrie continues to be a pivotal figure in biomedical research. Her latest patents signify her commitment to combating bacterial infections and enhancing public health through scientific advancements.